Click Here for 5% Off Your First Aladdin Purchase!

PD184352 (CI-1040) - ≥98%, high purity , Dual specificity mitogen-activated protein kinase kinase 2 inhibitor, CAS No.212631-79-3, Dual specificity mitogen-activated protein kinase kinase 2 inhibitor

  • Moligand™
  • ≥98%
Item Number
C125418
Grouped product items
SKUSizeAvailabilityPrice Qty
C125418-25mg
25mg
In stock
$195.90
C125418-100mg
100mg
In stock
$510.90
C125418-250mg
250mg
In stock
$1,149.90
C125418-500mg
500mg
In stock
$2,069.90

Selective MEK inhibitor

Basic Description

Synonyms212631-79-3|CI-1040|PD184352|PD 184352|PD-184352|2-(2-chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide|PD184352 (CI-1040)|CI 1040|2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide|CI1040|PD 184,352|2-((2-Chlor
Specifications & Purity≥98%
Legal InformationSold for only research purposes
Storage TempStore at -20°C
Shipped InDry ice
GradeMoligand™
Action TypeALLOSTERIC MODULATOR, INHIBITOR
Mechanism of actionDual specificity mitogen-activated protein kinase kinase 2 inhibitor
Product Description

PD184352 (CI-1040) is an ATP non-competitive MEK1/2 inhibitor with IC50 of 17 nM, 100-fold more selective for MEK1/2 than MEK5
A MEK inhibitor.

Product Properties

ALogP5.6

Associated Targets

CSNK2A1 Tchem Casein kinase II subunit alpha 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

RAF1 Tclin RAF proto-oncogene serine/threonine-protein kinase 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAP2K1 Tclin Dual specificity mitogen-activated protein kinase kinase 1 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide
INCHI InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)
InChi Key GFMMXOIFOQCCGU-UHFFFAOYSA-N
Canonical SMILES C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl
Isomeric SMILES C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl
WGK Germany 3
PubChem CID 6918454
Molecular Weight 478.66

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot NumberCertificate TypeDateItem
H2206149Certificate of AnalysisMay 11, 2024 C125418
H2206150Certificate of AnalysisMay 11, 2024 C125418
H2206151Certificate of AnalysisMay 11, 2024 C125418
H2206152Certificate of AnalysisMay 11, 2024 C125418

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 47.87, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 11.97, Max Conc. mM: 25

Safety and Hazards(GHS)

Pictogram(s) GHS09
Signal Warning
Hazard Statements

H400:Very toxic to aquatic life

Precautionary Statements

P273:Avoid release to the environment.

P501:Dispose of contents/container to ...

P391:Collect spillage.

WGK Germany 3

Related Documents

References

1. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S et al..  (1999)  Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo..  Nat Med,  (7): (810-6).  [PMID:10395327]
2. Davies SP, Reddy H, Caivano M, Cohen P.  (2000)  Specificity and mechanism of action of some commonly used protein kinase inhibitors..  Biochem J,  351  (Pt 1): (95-105).  [PMID:10998351]

Solution Calculators